title: Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
authors.forename: Philippe
authors.initials: P
authors.lastname: Rousselot
authors.forename: Jérome
authors.initials: J
authors.lastname: Larghero
authors.forename: Emmanuel
authors.initials: E
authors.lastname: Raffoux
authors.forename: Fabien
authors.initials: F
authors.lastname: Calvo
authors.forename: Michel
authors.initials: M
authors.lastname: Tulliez
authors.forename: Stéphane
authors.initials: S
authors.lastname: Giraudier
authors.forename: Michel
authors.initials: M
authors.lastname: Rybojad
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D003875:Drug Eruptions / Q000209:etiology*; D006801:Humans; D000068877:Imatinib Mesylate; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D008875:Middle Aged; D010787:Photosensitivity Disorders / Q000139:chemically induced*; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate